Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01295762 : Immunomonitoring of Children With Neuroblastoma
PhaseN/A
AgesMin: N/A Max: 21 Years
Eligibility
Inclusion Criteria:

- Age <= 21 years

- Patient with neuroblastoma any stage, in the first line or relapsed, or suspicion of
neuroblastoma

- Covered by a medical insurance

- Written, signed informed consent (patient, and parents if minor child)

Exclusion Criteria:

- Patients who received corticosteroids within 15 days prior to sampling

- Patients receiving immunosuppressive therapy

- Chemotherapy before sampling began

- Neuroblastoma in a genetic syndrome predisposing

- Deterioration of clinical status
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01295762      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740